CA2439216A1 - Intravascular device and method for axially stretching blood vessels - Google Patents
Intravascular device and method for axially stretching blood vessels Download PDFInfo
- Publication number
- CA2439216A1 CA2439216A1 CA002439216A CA2439216A CA2439216A1 CA 2439216 A1 CA2439216 A1 CA 2439216A1 CA 002439216 A CA002439216 A CA 002439216A CA 2439216 A CA2439216 A CA 2439216A CA 2439216 A1 CA2439216 A1 CA 2439216A1
- Authority
- CA
- Canada
- Prior art keywords
- stretching
- blood vessel
- vessel
- shape memory
- stretching mechanism
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Abandoned
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
- A61F2/00—Filters implantable into blood vessels; Prostheses, i.e. artificial substitutes or replacements for parts of the body; Appliances for connecting them with the body; Devices providing patency to, or preventing collapsing of, tubular structures of the body, e.g. stents
- A61F2/82—Devices providing patency to, or preventing collapsing of, tubular structures of the body, e.g. stents
- A61F2/86—Stents in a form characterised by the wire-like elements; Stents in the form characterised by a net-like or mesh-like structure
- A61F2/88—Stents in a form characterised by the wire-like elements; Stents in the form characterised by a net-like or mesh-like structure the wire-like elements formed as helical or spiral coils
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
- A61F2/00—Filters implantable into blood vessels; Prostheses, i.e. artificial substitutes or replacements for parts of the body; Appliances for connecting them with the body; Devices providing patency to, or preventing collapsing of, tubular structures of the body, e.g. stents
- A61F2/82—Devices providing patency to, or preventing collapsing of, tubular structures of the body, e.g. stents
- A61F2/86—Stents in a form characterised by the wire-like elements; Stents in the form characterised by a net-like or mesh-like structure
- A61F2/88—Stents in a form characterised by the wire-like elements; Stents in the form characterised by a net-like or mesh-like structure the wire-like elements formed as helical or spiral coils
- A61F2/885—Stents in a form characterised by the wire-like elements; Stents in the form characterised by a net-like or mesh-like structure the wire-like elements formed as helical or spiral coils comprising a coil including a plurality of spiral or helical sections with alternate directions around a central axis
Abstract
Intravascular devices and methods are provided for forming a vascular graft by axially distending a blood vessel to induce growth. These devices advantageously can be implanted via a catheter, thereby eliminating the need for a more invasive implantation procedure when the stretching is to be done in vivo. Preferably, the device for axially distending a blood vessel to induce growth of the vessel includes an intravascular stretching mechanism attachable directly to an interior lumen portion of the blood vessel, and a means for operating the stretching mechanism to cause the vessel to distend axially. The stretching mechanism can include a pair of wires or stents that engage the blood vessel wall. Components of the stretching mechanism can include a shape memory material.
Description
INTRAVASCULAR DEVICE AND METHOD
FOR AXIALLY STRETCHING BLOOD VESSELS
Background of the Invention The present invention is generally in the area of methods and devices for producing vascular tissue grafts from living vascular tissue, and particularly for malting autologous grafts.
Vascular grafts are commonly used by surgeons to bypass obstructions to blood flow caused by the presence of atherosclerotic plaques. Vascular grafts also are used in other applications such as providing arterial-venous shunts in dialysis patients, vascular repair or replacement and treating aneurysms. Grafts for bypass are often, but not exclusively, used in the coronary arteries, the arteries that supply blood to the heart.
The materials used to construct a vascular graft usually are either synthetic or of biological origin, but combinations of synthetic and biological materials are under development. The most widely used biological vascular grafts are autologous saphenous vein or mammary artery. Some common synthetic grafts are made of polytetrafluoroethylene (PTFE) (e.g., GORTEXTM) or polyester (e.g., DACRONTM). Autologous grafts have generally been used more successfully than synthetic grafts. Autologous grafts remain patent (functional) much longer than synthetic grafts, and saphenous veins often fail in less than five years. The short lifetime of synthetic grafts is especially evident with small diameter (less than 7 mm diameter) grafts, as most small diameter synthetic grafts occlude witlun one to two years or less.
Small diameter vascular grafts are particularly used in coronary artery bypass surgery.
Internal mammary artery (IMA) is the autologous graft of choice, because it typically has a longer life than venous grafts (95% patent at five years versus 85% patent at two years).
Mammary arterial tissue, however, is difficult to harvest, is typically not available in lengths sufficient for multiple bypasses, and its removal can result in problems such as problematic wound healing. Moreover, obtaining sufficient venous tissue for repairing an occluded artery can be problematic in patients with venous conditions such as varicose veins and especially in second or third surgeries in the same patient. Literature also suggests that IMA used in bypass procedures either fails soon after transplantation or remains patent indefinitely. See, e.g., Bergsma, et al., Circulation 97(24):2402-OS (1998); Cooley, Cif°culatiora 97(24):2384-85 (1998).
Other arteries such as the gastroepipolic, gastric, radial, and splenic also are used in coronary bypass procedures. In some cases, autologous or homologous saphenous vein preserved by freezing or other processes is used. A recent American Heart Association /
American College of Cardiology consensus document strongly recommends a move to total arterial revascularization (Eagle, et al. "ACC/AHA Guidelines for coronary artery bypass graft surgery: A report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines", Committee to Revise the 1991 Guidelines for Coronary Artery Bypass Graft Surgery, American College of Cardiology/American Heart Association, J. Ayn.
Coll. Cardiol., 34(4):1262-347 (1999)).
Development of a longer lasting small-diameter vascular graft is the subject of much academic and industrial research. One current approach is to combine cell culture and biomaterials technologies to make a living, "tissue engineered" graft. This effort, however, is hindered by the requirements of a successful graft. The graft should be self repairing, non-immunogenic, non-toxic, and non-thrombogenic; should have a compliance comparable to the artery being repaired; should be easily sutured by a surgeon; and should not require any special techniques or handling procedures. Grafts having these characteristics are difficult to achieve. Despite the substantial effort to date and the potential for significant financial reward, academic and industrial investigators have failed to produce graft materials that have demonstrated efficacy in human testing.
Efforts to avoid or minimize the need for vascular grafts for repair of otherwise healthy vascular tissue have been described. For example, Ruiz-Razura et al., J.
Reconstructive Microsurgery, 10(6):367-73 (1994) and Stark et al., Plastic &
Reconstructive Surgery, 80(4):570-78 (1987) disclose the use of a round microvascular tissue expander for acute arterial elongation to examine the effects on the tissue of such acute hyperextension.
The expander is a silicone balloon that is placed under the vessel to be elongated. The balloon is filled with saline over a very short period, causing acute stretching and elongation of the vessel. The method is purported to be effective for closure of arterial defects up to 30 mm without the need for a vein graft. These techniques are appropriate for trauma, but are not used for restoring blood flow in vessels that are occluded, for example by disease, which are treated by surgically bypassing the obstruction with a graft. The disclosed methods and devices fail to provide an autologous graft or versatile substitute. Moreover, the acute stretching may damage the vessel.
It has been demonstrated, however, that axial stretching can increase smooth muscle cell proliferation in an intact blood vessel, thereby substantially enhancing blood vessel growth. See Conklin, "Piability of Porcine Common Carotid Arteries in a Novel Orgafz
FOR AXIALLY STRETCHING BLOOD VESSELS
Background of the Invention The present invention is generally in the area of methods and devices for producing vascular tissue grafts from living vascular tissue, and particularly for malting autologous grafts.
Vascular grafts are commonly used by surgeons to bypass obstructions to blood flow caused by the presence of atherosclerotic plaques. Vascular grafts also are used in other applications such as providing arterial-venous shunts in dialysis patients, vascular repair or replacement and treating aneurysms. Grafts for bypass are often, but not exclusively, used in the coronary arteries, the arteries that supply blood to the heart.
The materials used to construct a vascular graft usually are either synthetic or of biological origin, but combinations of synthetic and biological materials are under development. The most widely used biological vascular grafts are autologous saphenous vein or mammary artery. Some common synthetic grafts are made of polytetrafluoroethylene (PTFE) (e.g., GORTEXTM) or polyester (e.g., DACRONTM). Autologous grafts have generally been used more successfully than synthetic grafts. Autologous grafts remain patent (functional) much longer than synthetic grafts, and saphenous veins often fail in less than five years. The short lifetime of synthetic grafts is especially evident with small diameter (less than 7 mm diameter) grafts, as most small diameter synthetic grafts occlude witlun one to two years or less.
Small diameter vascular grafts are particularly used in coronary artery bypass surgery.
Internal mammary artery (IMA) is the autologous graft of choice, because it typically has a longer life than venous grafts (95% patent at five years versus 85% patent at two years).
Mammary arterial tissue, however, is difficult to harvest, is typically not available in lengths sufficient for multiple bypasses, and its removal can result in problems such as problematic wound healing. Moreover, obtaining sufficient venous tissue for repairing an occluded artery can be problematic in patients with venous conditions such as varicose veins and especially in second or third surgeries in the same patient. Literature also suggests that IMA used in bypass procedures either fails soon after transplantation or remains patent indefinitely. See, e.g., Bergsma, et al., Circulation 97(24):2402-OS (1998); Cooley, Cif°culatiora 97(24):2384-85 (1998).
Other arteries such as the gastroepipolic, gastric, radial, and splenic also are used in coronary bypass procedures. In some cases, autologous or homologous saphenous vein preserved by freezing or other processes is used. A recent American Heart Association /
American College of Cardiology consensus document strongly recommends a move to total arterial revascularization (Eagle, et al. "ACC/AHA Guidelines for coronary artery bypass graft surgery: A report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines", Committee to Revise the 1991 Guidelines for Coronary Artery Bypass Graft Surgery, American College of Cardiology/American Heart Association, J. Ayn.
Coll. Cardiol., 34(4):1262-347 (1999)).
Development of a longer lasting small-diameter vascular graft is the subject of much academic and industrial research. One current approach is to combine cell culture and biomaterials technologies to make a living, "tissue engineered" graft. This effort, however, is hindered by the requirements of a successful graft. The graft should be self repairing, non-immunogenic, non-toxic, and non-thrombogenic; should have a compliance comparable to the artery being repaired; should be easily sutured by a surgeon; and should not require any special techniques or handling procedures. Grafts having these characteristics are difficult to achieve. Despite the substantial effort to date and the potential for significant financial reward, academic and industrial investigators have failed to produce graft materials that have demonstrated efficacy in human testing.
Efforts to avoid or minimize the need for vascular grafts for repair of otherwise healthy vascular tissue have been described. For example, Ruiz-Razura et al., J.
Reconstructive Microsurgery, 10(6):367-73 (1994) and Stark et al., Plastic &
Reconstructive Surgery, 80(4):570-78 (1987) disclose the use of a round microvascular tissue expander for acute arterial elongation to examine the effects on the tissue of such acute hyperextension.
The expander is a silicone balloon that is placed under the vessel to be elongated. The balloon is filled with saline over a very short period, causing acute stretching and elongation of the vessel. The method is purported to be effective for closure of arterial defects up to 30 mm without the need for a vein graft. These techniques are appropriate for trauma, but are not used for restoring blood flow in vessels that are occluded, for example by disease, which are treated by surgically bypassing the obstruction with a graft. The disclosed methods and devices fail to provide an autologous graft or versatile substitute. Moreover, the acute stretching may damage the vessel.
It has been demonstrated, however, that axial stretching can increase smooth muscle cell proliferation in an intact blood vessel, thereby substantially enhancing blood vessel growth. See Conklin, "Piability of Porcine Common Carotid Arteries in a Novel Orgafz
2 Culture System" MS Thesis, Georgia Institute of Technology, 1997); Han, et al., "Axial Stretch Increases Cell Proliferation in Arteries in Organ Culture", Advances in Bioengineering, ASME, BED 48:63-64 (2000).
PCT WO 99160952 to Georgia Tech Research Corporation and U.S. Patent No.
6,322,553 to Vito describe devices and methods for producing axial growth by mechanically stimulating a blood vessel using axial distention. These devices anchor to exterior surfaces of the blood vessels, and consequently their use in vivo is necessarily invasive, at least requiring endoscopic surgery. The size of the devices also may limit the sites that are suitable for implantation. It would be advantageous to develop devices and methods that are less invasive and more easily installed and used ih vivo. It would also be tremendously beneficial to the patient to be able to eliminate the need for surgery before removal of the grown blood vessel for use as an autologous graft.
It is therefore an object of the present invention to provide minimally- or non-invasive devices and methods fox stretching and growing blood vessels iya vivo.
It is another object of the present invention to provide simple devices and methods for creating natural blood vessel suitable for grafting.
It is a further object of the present invention to provide devices and methods for malting an autologous blood vessel graft with fewer surgeries.
These and other objects, features, and advantages of the present invention will become apparent upon review of the following detailed description of the invention tal~en in conjunction with the drawings and the appended claims.
Summary of the Invention Intravascular devices and methods are provided for forming a vascular graft by axially distending a blood vessel to stimulate vessel growth. These devices advantageously can be implanted via a catheter, thereby eliminating the need for a more invasive implantation procedure when the stretching is to be done in vivo. Where the vessel donor is the recipient of the graft, a totally autologous, living vascular graft is provided.
The device for axially distending a blood vessel to induce growth of the vessel includes an intravascular stretching mechanism attachable directly to an interior lumen portion of the blood vessel, and a means for operating the stretching mechanism to cause the vessel to distend axially. In a preferred embodiment, the intravascular stretching mechanism is composed of an anchoring wire and a stretching wire, wherein the distal end portions of these wires are separately anchorable to the interior lumen portion at positions axially remote from
PCT WO 99160952 to Georgia Tech Research Corporation and U.S. Patent No.
6,322,553 to Vito describe devices and methods for producing axial growth by mechanically stimulating a blood vessel using axial distention. These devices anchor to exterior surfaces of the blood vessels, and consequently their use in vivo is necessarily invasive, at least requiring endoscopic surgery. The size of the devices also may limit the sites that are suitable for implantation. It would be advantageous to develop devices and methods that are less invasive and more easily installed and used ih vivo. It would also be tremendously beneficial to the patient to be able to eliminate the need for surgery before removal of the grown blood vessel for use as an autologous graft.
It is therefore an object of the present invention to provide minimally- or non-invasive devices and methods fox stretching and growing blood vessels iya vivo.
It is another object of the present invention to provide simple devices and methods for creating natural blood vessel suitable for grafting.
It is a further object of the present invention to provide devices and methods for malting an autologous blood vessel graft with fewer surgeries.
These and other objects, features, and advantages of the present invention will become apparent upon review of the following detailed description of the invention tal~en in conjunction with the drawings and the appended claims.
Summary of the Invention Intravascular devices and methods are provided for forming a vascular graft by axially distending a blood vessel to stimulate vessel growth. These devices advantageously can be implanted via a catheter, thereby eliminating the need for a more invasive implantation procedure when the stretching is to be done in vivo. Where the vessel donor is the recipient of the graft, a totally autologous, living vascular graft is provided.
The device for axially distending a blood vessel to induce growth of the vessel includes an intravascular stretching mechanism attachable directly to an interior lumen portion of the blood vessel, and a means for operating the stretching mechanism to cause the vessel to distend axially. In a preferred embodiment, the intravascular stretching mechanism is composed of an anchoring wire and a stretching wire, wherein the distal end portions of these wires are separately anchorable to the interior lumen portion at positions axially remote from
3 one another. The device may further include a catheter having at least two lumens that are suitable for delivering the stretching wire and the anchor wire into the interior lumen portion of the blood vessel. The catheter and wires can be provided as a kit or an assembled device.
The distal end portion of the anchoring wire, the distal end portion of the stretching wire, or both, can include or be formed of a shape memory material.
Preferably, the shape memory material comprises nickel-titanium or a shape memory polymer. In operation of such an embodiment, the shape memory material changes shape in response to an effective temperature change, such as the temperature increase experienced following insertion of the material into a live mammalian body. The shape change, for example, can cause the distal end portion of the stretching wire to change from a substantially straight form into a spiral configuration which frictionally engages a first position in the interior lumen portion of the blood vessel and then can cause the distal end portion of the anchoring wire to change from a substantially straight form into a spiral configuration which engages a second position in the interior lumen portion of the blood vessel. Stretching forces can then be applied to the wires) to push/pull the distal portions away from each other.
In one variation, the stretching wire can further include an intermediary portion which changes shape, for example by use of a shape memory material, from a substantially straight form into a helical configuration which functions as a compression spring to impart the stretching forces.
The means for operating the stretching mechanism can include a prime mover that is mechanically, electromechanically, or hydraulically driven. This operating means can cause the axial stretching force to be applied to the vessel in a continuous, intermittent, or cyclical manner, and applied rectilinearly, curvilinearly, or in a combination thereof.
The device can also include a controller for controlling the means for operating the stretching mechanism.
In another preferred embodiment, the intravascular stretching mechanism comprises a first stmt, a second stmt, and a compression spring operably connected to the first stmt and the second stmt, wherein the first and second stems are separately anchorable to the interior lumen portion at positions axially remote from one another. In this embodiment, the first stmt, the second stmt, the compression spring, or a combination thereof, can include a shape memory material, such as a nickel-titanium alloy or a shape memory polymer.
In any of these embodiments, the intravascular stretching mechanism, or a portion thereof, can include a therapeutic or prophylactic agent, such as a growth-stimulating agent, which can be released in an effective amount to enhance growth of the blood vessel. Another example is an anti-throbotic agent to minimize the rislc of a blood clot during the stretching
The distal end portion of the anchoring wire, the distal end portion of the stretching wire, or both, can include or be formed of a shape memory material.
Preferably, the shape memory material comprises nickel-titanium or a shape memory polymer. In operation of such an embodiment, the shape memory material changes shape in response to an effective temperature change, such as the temperature increase experienced following insertion of the material into a live mammalian body. The shape change, for example, can cause the distal end portion of the stretching wire to change from a substantially straight form into a spiral configuration which frictionally engages a first position in the interior lumen portion of the blood vessel and then can cause the distal end portion of the anchoring wire to change from a substantially straight form into a spiral configuration which engages a second position in the interior lumen portion of the blood vessel. Stretching forces can then be applied to the wires) to push/pull the distal portions away from each other.
In one variation, the stretching wire can further include an intermediary portion which changes shape, for example by use of a shape memory material, from a substantially straight form into a helical configuration which functions as a compression spring to impart the stretching forces.
The means for operating the stretching mechanism can include a prime mover that is mechanically, electromechanically, or hydraulically driven. This operating means can cause the axial stretching force to be applied to the vessel in a continuous, intermittent, or cyclical manner, and applied rectilinearly, curvilinearly, or in a combination thereof.
The device can also include a controller for controlling the means for operating the stretching mechanism.
In another preferred embodiment, the intravascular stretching mechanism comprises a first stmt, a second stmt, and a compression spring operably connected to the first stmt and the second stmt, wherein the first and second stems are separately anchorable to the interior lumen portion at positions axially remote from one another. In this embodiment, the first stmt, the second stmt, the compression spring, or a combination thereof, can include a shape memory material, such as a nickel-titanium alloy or a shape memory polymer.
In any of these embodiments, the intravascular stretching mechanism, or a portion thereof, can include a therapeutic or prophylactic agent, such as a growth-stimulating agent, which can be released in an effective amount to enhance growth of the blood vessel. Another example is an anti-throbotic agent to minimize the rislc of a blood clot during the stretching
4 process. The therapeutic or prophylactic agent can be impregnated in or coated onto the device components, and/or added and released through a lumen in the catheter that delivers the device to its intravascular position.
Methods are provided for distending a blood vessel of a human or animal to induce blood vessel growth. The steps include (i) inserting into an interior lumen portion of a blood vessel the stretching mechanism of the devices described herein; (ii) anchoring the stretching mechanism to the interior lwnen portion at at least two positions which are axially remote from one another; and (iii) operating the stretching mechanism to axially stretch the blood vessel between said at least two positions over a period of time effective to induce axial growth of the blood vessel. This operation step could be active (e.g., applying an external force to the mechanism or a component thereof) or passive (e.g., simply releasing an elastic force, such as a spring). The stretching can be performed in vivo or ih vitro in a medium for cell growth.
Methods are also provided for forming a vascular graft for a human patient in need thereof. The methods include the steps of distending a donor blood vessel by use of one of the intravascular stretching devices and methods described herein, and then excising a portion of the distended donor vessel, that portion thereby providing a vascular graft.
While a variety of blood vessel types could be stretched as described herein, the blood vessel preferably is selected from an internal mammary artery, a femoral artery, a gastroepipolic artery, a gastric artery, a radial artery, and a splenic artery, when stretching the vessel to form a vascular graft.
Brief Description of the Drawings Figure 1 is a perspective view of the parts of one embodiment of the intravascular device, which includes a multi-lumen catheter, an anchor wire, and stretching wire.
Figure 2 is a perspective view of a wire having a distal end portion comprising a shape memory material in a straight configuration (Fig. 2A) and in a spiral configuration (Fig. 2B).
Figures 3A-E are partial cross-sectional views of a blood vessel in which one embodiment of the intravascular device is being deployed and operated to stretch the blood vessel, using external force to push an anchored stretching wire away from an anchor wire.
Figure 4 is a perspective view of a wire having a distal end portion comprising a shape memory material in a straight configuration (Fig. 4A) and in a complex configuration having a spiral end and a compression spring (Fig. 4B).
Figures SA-E are partial cross-sectional views of a blood vessel in which a second embodiment of the intravascular device is being deployed and operated to stretch the blood
Methods are provided for distending a blood vessel of a human or animal to induce blood vessel growth. The steps include (i) inserting into an interior lumen portion of a blood vessel the stretching mechanism of the devices described herein; (ii) anchoring the stretching mechanism to the interior lwnen portion at at least two positions which are axially remote from one another; and (iii) operating the stretching mechanism to axially stretch the blood vessel between said at least two positions over a period of time effective to induce axial growth of the blood vessel. This operation step could be active (e.g., applying an external force to the mechanism or a component thereof) or passive (e.g., simply releasing an elastic force, such as a spring). The stretching can be performed in vivo or ih vitro in a medium for cell growth.
Methods are also provided for forming a vascular graft for a human patient in need thereof. The methods include the steps of distending a donor blood vessel by use of one of the intravascular stretching devices and methods described herein, and then excising a portion of the distended donor vessel, that portion thereby providing a vascular graft.
While a variety of blood vessel types could be stretched as described herein, the blood vessel preferably is selected from an internal mammary artery, a femoral artery, a gastroepipolic artery, a gastric artery, a radial artery, and a splenic artery, when stretching the vessel to form a vascular graft.
Brief Description of the Drawings Figure 1 is a perspective view of the parts of one embodiment of the intravascular device, which includes a multi-lumen catheter, an anchor wire, and stretching wire.
Figure 2 is a perspective view of a wire having a distal end portion comprising a shape memory material in a straight configuration (Fig. 2A) and in a spiral configuration (Fig. 2B).
Figures 3A-E are partial cross-sectional views of a blood vessel in which one embodiment of the intravascular device is being deployed and operated to stretch the blood vessel, using external force to push an anchored stretching wire away from an anchor wire.
Figure 4 is a perspective view of a wire having a distal end portion comprising a shape memory material in a straight configuration (Fig. 4A) and in a complex configuration having a spiral end and a compression spring (Fig. 4B).
Figures SA-E are partial cross-sectional views of a blood vessel in which a second embodiment of the intravascular device is being deployed and operated to stretch the blood
5 vessel, using an integral compression spring to push an anchored stretching wire away from an anchor wire.
Figure 6 is a side view of one embodiment of the intravascular stretching device, which includes two stems and an integral compression spring, which comprises a shape memory material, shown in a compressed configuration (Fig. 6A) and in an expanded configuration (Fig. 6B).
Figure 7 is a side view of a stmt and its integral compression spring, which form part of one embodiment of the intravascular stretching device.
Figure 8 is a side or plan view of a one embodiment of the intravascular stretching I O device, which includes two stems and an integral compression spring shown in a compressed configuration (Fig. 8A) and in a curvilinear expanded configuration (Fig. 8B).
Detailed Description of the Invention It is known that smooth muscle cells, which dominate the media, the major load I S bearing layer of the arterial wall, proliferate and increase their production of extracellular matrix in response to mechanical stimulation. It was discovered that this knowledge could be advantageously applied to create an autologous graft of appropriate diameter for coronary bypass or other vascular graft application using an intravascular distension device to stimulate angiogenesis.
20 The distension device secures the donor blood vessel at different points within the vessel and then distends or stretches the vessel between those points to form an elongated portion. The elongated portion can then be excised for use as a vascular graft. The devices and methods described herein can used to male allogeneic and xenogeneic vascular grafts, as well as the more preferred autogeneic vascular grafts.
25 The Devices and Methods of Oueration The device includes a stretching mechanism that can be attached to and within a donor blood vessel, and a means for operating the stretching mechanism to cause the vessel to distend (i.e. extend), and an optional controller for controlling the operating means. At least two anchoring points are needed to stretch the blood vessel. In preferred embodiments of the 30 intravascular distention device and method, the axial forces for stretching the blood vessel axe applied to at least one element of two or more elements, or portions thereof, that are secured (i.e. anchored) to the interior surface of the blood vessel to be stretched.
These elements constitute the intravascular stretching mechanism, and preferably can be delivered into the blood vessel by a catheter for installation and use.
Figure 6 is a side view of one embodiment of the intravascular stretching device, which includes two stems and an integral compression spring, which comprises a shape memory material, shown in a compressed configuration (Fig. 6A) and in an expanded configuration (Fig. 6B).
Figure 7 is a side view of a stmt and its integral compression spring, which form part of one embodiment of the intravascular stretching device.
Figure 8 is a side or plan view of a one embodiment of the intravascular stretching I O device, which includes two stems and an integral compression spring shown in a compressed configuration (Fig. 8A) and in a curvilinear expanded configuration (Fig. 8B).
Detailed Description of the Invention It is known that smooth muscle cells, which dominate the media, the major load I S bearing layer of the arterial wall, proliferate and increase their production of extracellular matrix in response to mechanical stimulation. It was discovered that this knowledge could be advantageously applied to create an autologous graft of appropriate diameter for coronary bypass or other vascular graft application using an intravascular distension device to stimulate angiogenesis.
20 The distension device secures the donor blood vessel at different points within the vessel and then distends or stretches the vessel between those points to form an elongated portion. The elongated portion can then be excised for use as a vascular graft. The devices and methods described herein can used to male allogeneic and xenogeneic vascular grafts, as well as the more preferred autogeneic vascular grafts.
25 The Devices and Methods of Oueration The device includes a stretching mechanism that can be attached to and within a donor blood vessel, and a means for operating the stretching mechanism to cause the vessel to distend (i.e. extend), and an optional controller for controlling the operating means. At least two anchoring points are needed to stretch the blood vessel. In preferred embodiments of the 30 intravascular distention device and method, the axial forces for stretching the blood vessel axe applied to at least one element of two or more elements, or portions thereof, that are secured (i.e. anchored) to the interior surface of the blood vessel to be stretched.
These elements constitute the intravascular stretching mechanism, and preferably can be delivered into the blood vessel by a catheter for installation and use.
6 The securing preferably is by frictional engagement, rather than with the use of other possible securing means such as adhesives or sutures. This engagement can be implemented with shape-changing materials, as detailed below, or with non-shape changing materials, which for example, may require balloon dilation to cause at least a portion of the stretching mechanism to expand and engage the interior lumen portion of the blood vessel.
As the secured elements axe displaced from one another, the blood vessel segment therebetween experiences axial stretching forces.
In a first preferred embodiment, the intravascular stretching mechanism includes a pair of wires, the end portions of which can be anchored within the blood vessel, and a means to displace the wires away from each other and stretch the vessel. The blood vessel can be displaced (i.e. stretched) in rectilinearly, curvilinearly, or in a combination thereof. This displacement can be accomplished by any of a variety of techniques, for example, by mechanical, electromechanical, or hydraulic means.
In a second preferred embodiment, the intravascular stretching mechanism comprises a pair of stems connected by a compression spring, which operates as a mews to displace the stents away from each other and stretch the vessel. As used herein, the term "stmt" refers to an elastic, expandable, generally cylindrical anchor capable of engaging a blood vessel wall and resisting axial forces; it may or may not be structurally like a conventional stmt, which primarily serves to resist radial forces.
It is possible that components of these two different designs can be combined, for example, using a combination of stems and wires to perform the stretching process. It is also envisioned that these anchoring elements can take the form of other suitable structures now known or later developed, as the choice of anchoring elements generally can be considered a matter of design choice.
A. Des~'m Utilizing Anchored Wires In some embodiments, the device employs two wires anchored within the blood vessel to be stretched. Examples of these are shown in Figures 1-5 and described below.
The Deuice ahd Cof~2~onents Thereof As shown in Figure 1, a kit 10 includes a multi-lumen catheter 12 and at least two wires: a stretching wire 14a and an anchor wire 14b. The catheter 12 has proximal end 16 and opposed distal end 18, and has four lumens,17a, 17b, 17c, and 17d.
The catheter and wires can be provided as a kit or an assembled device. The catheter can be a standard, commercially available catheter. The catheter preferably has at least two lumens, one for each of the two wires. Additional lumens can be included for cold saline or
As the secured elements axe displaced from one another, the blood vessel segment therebetween experiences axial stretching forces.
In a first preferred embodiment, the intravascular stretching mechanism includes a pair of wires, the end portions of which can be anchored within the blood vessel, and a means to displace the wires away from each other and stretch the vessel. The blood vessel can be displaced (i.e. stretched) in rectilinearly, curvilinearly, or in a combination thereof. This displacement can be accomplished by any of a variety of techniques, for example, by mechanical, electromechanical, or hydraulic means.
In a second preferred embodiment, the intravascular stretching mechanism comprises a pair of stems connected by a compression spring, which operates as a mews to displace the stents away from each other and stretch the vessel. As used herein, the term "stmt" refers to an elastic, expandable, generally cylindrical anchor capable of engaging a blood vessel wall and resisting axial forces; it may or may not be structurally like a conventional stmt, which primarily serves to resist radial forces.
It is possible that components of these two different designs can be combined, for example, using a combination of stems and wires to perform the stretching process. It is also envisioned that these anchoring elements can take the form of other suitable structures now known or later developed, as the choice of anchoring elements generally can be considered a matter of design choice.
A. Des~'m Utilizing Anchored Wires In some embodiments, the device employs two wires anchored within the blood vessel to be stretched. Examples of these are shown in Figures 1-5 and described below.
The Deuice ahd Cof~2~onents Thereof As shown in Figure 1, a kit 10 includes a multi-lumen catheter 12 and at least two wires: a stretching wire 14a and an anchor wire 14b. The catheter 12 has proximal end 16 and opposed distal end 18, and has four lumens,17a, 17b, 17c, and 17d.
The catheter and wires can be provided as a kit or an assembled device. The catheter can be a standard, commercially available catheter. The catheter preferably has at least two lumens, one for each of the two wires. Additional lumens can be included for cold saline or
7 other purposes. Selection of the appropriate diameter and length for the catheter will of course depend on the particular blood vessel selected for stretclung, as well as on the diameter and number of the anchor wires and stretching wires to be used.
The stretching wire 14a has proximal end portion 20a and distal end portion 22a, and the anchor wire 14b has proximal end portion 20b and distal end portion 22b.
Both the stretching wire and the anchor wire must be able to be secured to the interior surface of the blood vessel to be stretched. Figures 2A and 2B illustrate a wire 14 that can serve as the anchor wire, the stretching wire, or both. Wire 14 has a proximal end portion 20 and a distal end portion 22. Distal end portion 22 must be changeable from a straight configuration (Fig.
2A) into a second configuration that will fractionally engage the interior surface of the blood vessel. In a preferred embodiment, the second configuration is a spiral, as shown in Figure 2B. As used herein, the term "spiral" includes any helical, spiral, coiled, cylindrical, or curled shape.
The stretching wire 14a should be of a suitable gauge and material of construction so that it is resistant to buckling when subjected to the pushing (stretching) forces. This gauge and construction can be different from that of the anchor wire 14b, which undergoes a pulling, rather than pushing, force during vessel stretching.
In other embodiments, the stretching wire and/or anchor wire deploy into other, more complex configurations. For example, the stretching wire can deploy (e.g., upon warming to body temperature) into an anchoring spiral with a compression spring, as showing in Figures 4A-B. Figure 4A shows a stretching wire 40, having proximal end 41 and distal end 42, in its straight configuration, for example, at a temperature less than body temperature. Figure 4B
shows the stretching wire 40 with the distal end portion 42 transformed into a compression spring 44 portion and spiral anchor portion 46.
The wires can be fabricated using suitable materials and methods to accomplish the transformation of shape shown. For example, the wires can be maintained in a straight profile with a removable sleeve that snugly fits around the wire. Such a sleeve could simply be slid off the wire following insertion. The sleeve could be a separate component that fits within the catheter lumen or the catheter itself could serve the sleeve function. The shape change of the wire could be due to a spring action inherent in the material of construction of the wire, such that, upon sleeve removal the wire changes into the curled configuration. Such a transformation can occur because of the elastic restorative forces normally exhibited in most metals and polymeric materials, forces that could be made, by one skilled in the art, to straighten a curved wire formed from these materials.
The stretching wire 14a has proximal end portion 20a and distal end portion 22a, and the anchor wire 14b has proximal end portion 20b and distal end portion 22b.
Both the stretching wire and the anchor wire must be able to be secured to the interior surface of the blood vessel to be stretched. Figures 2A and 2B illustrate a wire 14 that can serve as the anchor wire, the stretching wire, or both. Wire 14 has a proximal end portion 20 and a distal end portion 22. Distal end portion 22 must be changeable from a straight configuration (Fig.
2A) into a second configuration that will fractionally engage the interior surface of the blood vessel. In a preferred embodiment, the second configuration is a spiral, as shown in Figure 2B. As used herein, the term "spiral" includes any helical, spiral, coiled, cylindrical, or curled shape.
The stretching wire 14a should be of a suitable gauge and material of construction so that it is resistant to buckling when subjected to the pushing (stretching) forces. This gauge and construction can be different from that of the anchor wire 14b, which undergoes a pulling, rather than pushing, force during vessel stretching.
In other embodiments, the stretching wire and/or anchor wire deploy into other, more complex configurations. For example, the stretching wire can deploy (e.g., upon warming to body temperature) into an anchoring spiral with a compression spring, as showing in Figures 4A-B. Figure 4A shows a stretching wire 40, having proximal end 41 and distal end 42, in its straight configuration, for example, at a temperature less than body temperature. Figure 4B
shows the stretching wire 40 with the distal end portion 42 transformed into a compression spring 44 portion and spiral anchor portion 46.
The wires can be fabricated using suitable materials and methods to accomplish the transformation of shape shown. For example, the wires can be maintained in a straight profile with a removable sleeve that snugly fits around the wire. Such a sleeve could simply be slid off the wire following insertion. The sleeve could be a separate component that fits within the catheter lumen or the catheter itself could serve the sleeve function. The shape change of the wire could be due to a spring action inherent in the material of construction of the wire, such that, upon sleeve removal the wire changes into the curled configuration. Such a transformation can occur because of the elastic restorative forces normally exhibited in most metals and polymeric materials, forces that could be made, by one skilled in the art, to straighten a curved wire formed from these materials.
8 In a preferred embodiment, this configuration-changing function is accomplished by having the wire, or at least the distal end portion thereof, include a suitable shape memory material. Shape memory materials typically have two distinct shapes, and the transition between these shapes can occur in response to various stimuli. A preferred transition stimulus is a change in temperature. For example, distal end 22 of wire 14 can designed to be straight at room temperature, e.g., about 20 °C, (Fig. 2A) and to form a spiral shape when warmed to human body temperature, e.g., about 37 °C, or above (Fig. 2B). Qther transition temperatures can be utilized.
Nickel-titanium alloys (e.g., Ninitol) that exhibit super-elastic and shape-memory effects are particularly suitable. Other shape memory alloys and shape memory polymeric materials also cal be used. For example, such shape memory materials can be fabricated to change shape from straight to spiral as the wires warm to body temperature following ih vivo insertion. Examples of shape memory polymers and other shape memory materials are described, for example, in PCT WO 99/42528 to MIT; U.S. Patent No. 6,160,084 to Langer et al.; and Shape Memory Materials, (Otsuka & Wayman, eds.), Cambridge University Press (October 1999), which are hereby incorporated by reference. Methods for forming or coating wires with such materials are known to those spilled in the art.
In a preferred embodiment, the device is formed of a biodegradable shape memory polymer, such as described in U.S. Patent No. 6,160,084 to Langer et al. The specific polymer could be tailored to degrade following completion of the stretching procedure.
A device formed of such materials preferably would not need to be removed before vessel excision or grafting.
It is important to note that the "memory" of the shape memory material of the compression spring is not limited to axial recovery. The shape memory material can take the form of complex curves (e.g., S-shaped) during their expansion and recovery, thereby creating tortuous paths for the axial blood vessel growth and reducing axial differentiation between the anchoring elements while increasing the arterial path between them. See, e.g., Figure 8.
O~eratirag Means ahd Cohtr~olle~
The linear movement of the wires can be driven by a wide variety of forces and driver means known in the art. The movement also may be conducted using mechanical, electromechanical, hydraulic, or other means known for controllably pushinglpulling one structure relative to a second structure. Some of these are described in, or can be adapted from those describe in, U.S. Patent No. 6,322,553 to Vito, which is hereby incorporated by reference.
Nickel-titanium alloys (e.g., Ninitol) that exhibit super-elastic and shape-memory effects are particularly suitable. Other shape memory alloys and shape memory polymeric materials also cal be used. For example, such shape memory materials can be fabricated to change shape from straight to spiral as the wires warm to body temperature following ih vivo insertion. Examples of shape memory polymers and other shape memory materials are described, for example, in PCT WO 99/42528 to MIT; U.S. Patent No. 6,160,084 to Langer et al.; and Shape Memory Materials, (Otsuka & Wayman, eds.), Cambridge University Press (October 1999), which are hereby incorporated by reference. Methods for forming or coating wires with such materials are known to those spilled in the art.
In a preferred embodiment, the device is formed of a biodegradable shape memory polymer, such as described in U.S. Patent No. 6,160,084 to Langer et al. The specific polymer could be tailored to degrade following completion of the stretching procedure.
A device formed of such materials preferably would not need to be removed before vessel excision or grafting.
It is important to note that the "memory" of the shape memory material of the compression spring is not limited to axial recovery. The shape memory material can take the form of complex curves (e.g., S-shaped) during their expansion and recovery, thereby creating tortuous paths for the axial blood vessel growth and reducing axial differentiation between the anchoring elements while increasing the arterial path between them. See, e.g., Figure 8.
O~eratirag Means ahd Cohtr~olle~
The linear movement of the wires can be driven by a wide variety of forces and driver means known in the art. The movement also may be conducted using mechanical, electromechanical, hydraulic, or other means known for controllably pushinglpulling one structure relative to a second structure. Some of these are described in, or can be adapted from those describe in, U.S. Patent No. 6,322,553 to Vito, which is hereby incorporated by reference.
9 The device includes means to operate the stretching mechanism, preferably including a prime mover and electronic drivers for the prime mover. The prime mover can be an ehectro-mechanical (active) device, such as a linear motor that operates the stretching mechanism to push andlor pull the distal end of the stretching wire away from the distal end of the anchor wire. The operating means preferably is operably connected to the proximal end of at least the stretching wire.
A rotary motor could also be used to generate the required linear motion, using techniques known in the art. Alternatively, the prime mover can operate hydraulically. An active device generally requires input over time. The prime mover also can be a passive device such as a spring or a combination of a spring and a damper, where stored mechanical energy is used to push and/or pull the anchored portions of the wires away from each other.
Linear or rotary piezo micro-motor devices (actuators) deliver small step sizes, small forces, have relatively simple control electronics and inherent force overload protection.
Suitable devices are available from a number of vendors, including Micro Pulse Systems, Inc.
Parameters of the operating means include the force applied by the stretching mechanism, the rate and direction of movement of the stretching mechanism, the length of time that the stretching mechanism is operated, and the type of stretching applied (e.g., continuous, cyclical, or intermittent).
The controller controls the operating means. The controller can include a microprocessor that can be activated and programmed to control the stretching process. It preferably can be reprogrammed as needed to control the stretching process, based, for example, on x-ray data or other indications of how the process is proceeding.
The mechanical or hydraulic stretching mechanism works to move the wires apart slowly over a period of up to several weeks. In one embodiment, the passive driver element may be used to provide a pre-determined stretch over time. In another embodiment, the driver may be programmed to operate autonomously, for example to provide a stretch of several centimeters over about ane month. Alternatively, cyclic stretching of increasing peak and mean amplitude may be used. Using piezo actuators, activating the driver can produce incremental movements of the mechanical or hydraulic stretching mechanism as small as a few microns. The prime mover is designed to be force limited to preclude overstretching the vessel. Force limitation is inherent if the piezoelectric actuators are used in either embodiment and, in the case of permanent magnetic motors, can be designed into the electronic driver circuit.
Methods o Use The catheter can be inserted using well-established techniques for catheter insertion.
Briefly, a guide wire is inserted using an insertion catheter and is steered to the target blood vessel, usually by using fluoroscopic techniques. The catheter then slides over the guide wire so that its distal end is located in the lumen of the target blood vessel.
Insertion of the catheter is facilitated by its radio-opaque nature.
In the methods employing shape memory materials that can be activated by a temperature change, the anchor wire and stretching wire typically will need to be maintained at a temperature below body temperature until their distal ends are correctly positioned inside the target blood vessel lumen. Techniques for accomplishing this temperature control are well known to those skilled in the art. For example, chilled saline can be flowed through one or more of the catheter lumens to maintain the temperature of the wire that is inside a catheter lumen below the activation temperature.
The device described with reference to Figures 1 and 2 can be installed and operated as illustrated in Figures 3A-E. In these Figures, blood flow should be from left (proximal) to right (distal). Figure 3A shows a catheter 12 in an inserted position within target blood vessel 30, such that distal end 18 of catheter 12 is in the desired position for deployment of the stretching wire. As stretching wire 14a is deployed, its distal end portion 22a warms to body temperature and changes to a spiral, expanded configuration and engages circumferentially the interior surface 31 of blood vessel 30, as shown in Figure 3B. This engagement causes the stretching wire 14a to be secured to the blood vessel 30 and establishes a distal anchoring point therein.
Next, a proximal anchoring point is established. As shown in Figure 3C, the catheter is first moved proximally (to the left) such that distal end 18 of catheter 12 is in the desired position for deployment of the anchor wire. As anchor wire 14b is deployed, its distal end portion 22b warms to body temperature and changes to a spiral, expanded configuration and engages circumferentially the interior surface 32 of blood vessel 30, as shown in Figure 3D.
This engagement causes the anchor wire 14b to be secured to the blood vessel 30 and establishes a proximal anchoring point therein. These distal and proximal anchoring points, at surfaces 31 and 32, respectively, establish the blood vessel segment to be stretched.
Stretching forces axe then applied to one or both of the wires 14a and 14b.
Production and control of these stretching forces can be provided as described above.
Stretching can be continuous, cyclical, or intermittent, or in a combination thereof. Figure 3E
illustrates that the stretching wire 14a has been pushed and caused the blood vessel 30 to be stretched and grown between points 31 and 32. While the stretching shown in Figure 3E is linear (or rectilinear), stretching also can occur in curvilinear manner or in a combination of rectilinear and curvilinear stretching.
The device described with reference to Figures 1 and 3 can be installed and operated as illustrated in Figures SA-E. In these Figures, blood flow should be from left (proximal) to right (distal). Figure SA shows a catheter 12 in an inserted position within target blood vessel 30, such that distal end 18 of catheter 12 is in the desired position for deployment of the stretching wire. As stretching wire 40 is partially deployed, the tip end poxtion of distal end portion 42 warms to body temperature and changes to a spiral, expanded configuration, forming a spiral 46 which engages circumferentially the interior surface 31 of blood vessel 30, as shown in Figure SB. This engagement causes the stretching wire 14a to be secured to the blood vessel 30 and establishes a distal anchoring point therein.
As stretching wire 40 continues to be deployed, an intermediary portion of the distal end portion 42 transforms into a helical configuration operable as a compression spring 44, as shown in Figure SC. This compression spring 44 has an outer diameter that is smaller than that of the spiral 46, so that the compression spring 44 does not fractionally engage and become anchored to the blood vessel wall.
After the compression spring 44 is fully formed, a proximal anchoring point is established. As shown in Figure SD, the catheter is first moved proximally (to the left) such that distal end 18 of catheter 12 is in the desired position for deployment of the anchor wire.
As anchor wire 50 is deployed, its distal end portion 52 warms to body temperature and changes to a spiral, expanded configuration and engages circumferentially the interior surface 32 of blood vessel 30, as shown in Figure 3D. This engagement causes the anchor wire 50 to be secured to the blood vessel 30 and establishes a proximal anchoring point therein.
These distal and proximal anchoring points, at surfaces 31 and 32, respectively, establish the blood vessel segment to be stretched. Stretching forces are then applied by the release of compression in spring 44, which stretches the blood vessel 30 as shown in Figure SE. It may be convenient in this embodiment to simply leave the catheter in place while stretching occurs.
B. Design Utilizing Combination of Stents and Spryn~s In another embodiment, the intravascular stretching means comprises a pair of stems, wherein the stems, rather than the wire spirals described above, function as the anchoring elements. While a variety of stmt designs are commercially available or otherwise known for use in maintaining blood vessel diameter, the stems of the present methods and devices are designed and used to impart axial forces to increase the length of the vessel.
The Device ahd Compohehts Thereof One example of such a design is illustrated in Figures 6A-B. Figures 6A and 6B
show intravascular device 60, which is comprised of a proximal stmt 62, a distal stmt 64, and a compression spring 66 secured between the distal and proximal stems. One end of the proximal stent 62 is comlected to, or integral with, the proximal end 68a of compression spring 66, and one end of the distal stmt 64 is connected to, or integral with, the distal end 68b of compression spring 66. Figure 6A shows device 60 with spring 66 in its compressed configuration, and Figure 6B shows device 60 with spring 66 in its expanded, or stretched, configuration.
Essentially any stmt suitable for vascular implantation can be adapted for use in the present intravascular device. The stmt preferably is self expanding, but also can deployable by other means (e.g., balloon dilation). The stmt can be of various types, including but not limited to coil, mesh, and porous structures. One example of an expandable stmt is described in U.S. Patent No. 6,033,436 to Steinke, et al. Figure 7 shows one embodiment of a proximal or distal stmt 70, which is integral with compression spring 72 (only partially shown). This anchoring stmt 70 is the structural feature that positively engages the vessel wall (not shown).
Numerous other designs are known in the art or can be routinely adapted therefrom. Some configurations are described in U.S. Patent No. 6,193,744 to Ehr et al. These patents are hereby incorporated by reference.
Preferably, each stmt is between about 5 and 20 mm, more preferably about 10 mm, in length. The diameter of the stmt desirably is selected for the particular donor vessel, the size of which can vary.
The compression spring can be integrally formed with the stents, or the compression spring can be welded or otherwise attached to the stems following fabrication of each component. Preferably, the entire device is fabricated in one piece, i.e. as a single, contiguous assembly.
The device should be formed of and/or coated with a biocompatible material, as known in the art. Preferably, the compression spring is made of or includes a shape memory material, as describe herein (e.g., nickel-titanium alloys and shape memory polymers). The compression spring can alternatively be made from non-shape memory materials (e.g., titanium, stainless steel, or a biocompatible polymer). The stems preferably are also fabricated from a shape memory material, but may be made from a non-shape memory material, as describe herein.
Methods of Use The intravascular device is inserted into the target (i.e. donor) blood vessel. Then, the stems are self expanded (e.g., if they comprise a shape memory material) or are expanded with the use of an installation device, such as a balloon, using or adapting techniques known in the art. The expansion process causes each stmt to become frictionally engaged, and thus anchored, to a circmnferential portion of the interior surface of the blood vessel. The stems are anchored in positions such that the spring therebetween is in compression.
The spring thus exerts an axial, expansion force causing the section of blood vessel between the anchor points to be stretched. The expansion of the compression spring thus causes the length of that blood vessel section to lengthen.
Figures 8A-B illustrate one embodiment of a stmt-type stretching device 80 comprising stents 84 and 86 with compression spring 82 in a compressed configuration (Fig.
8A) and with the compression spring 82 in an expanded or stretched configuration (Fig. 8B).
Figure 8B illustrates how a blood vessel could be stretched in a curvilinear mariner to twice the original length, L. A stmt-type device also could expand to stretch in a.linear (or rectilinear) manner or in combination of curvilinear and rectilinear motion.
C. Other Design Features The methods and devices described herein optionally can include growth factors or other growth stimulating agents (e.g., hormones) to further enhance blood vessel growth. For example, such growth stimulating agents can be delivered to the blood vessel by impregnating the materials forming the wires, stems or other device components.
Alternatively or additionally, the device components can be provided with a suitable coating or reservoirs that can contain and controllably release such agents during the extension process.
Examples of growth factors include vascular endothelial growth factor (VEGF), endothelial cell growth factor (ECGF), basic fibroblast growth factor (bFGF), and platelet derived growth factor (PDGF). Biocompatible polymeric materials for controlled release that are lrnown in the art for drug delivery (see e.g., U.S. Patent No. 5,879,713 to Roth et al.) can be adapted for use with the devices described herein. The devices and methods also can be used in combination with external electric, magnetic, or electromagnetic fields applied as a growth stimulus. See e.g., U.S. Patent No. 4,846,181 to Miller.
The devices also can optionally include appropriate drugs (e.g., therapeutic or prophylactic agents) impregnated into or coated to structural components, for example to minimize infections, thrombosis, inflammatory reactions, scar tissue formation, adhesion formation, and/or other adverse tissue reactions. For example, where tissue growth is to be avoided, certain antifibrotic agents may be present, such as 5-fluourouracil or mitomycin. The device may be more generally provided with coatings that are antibiotic or anti-inflammatory.
The intravascular stretching device also can be designed to limit adhesion formation while installed in the blood vessel. For example, the wires, stems, compression springs, or other components can be impregnated or coated with materials selected to reduce adhesion formation as l~nown in the art. Examples of such coating materials include, but are not limited to, parylene, polytetrafluoroethylene (e.g., TEFLONTM) and chromium (e.g., ME-92~, Armoloy Corp.), which can be used to coat a variety of other metal and polymer substrates.
Application of the Distension Devices and Methods The present devices and methods are useful for forming a vascular graft by axially stretching (i.e. distending or extending) a donor blood vessel to stimulate growth. This stretching can performed iya vivo or in vitro.
While an autologous graft is preferred, the devices and methods described herein also can be applied to an artery from another human or other animal, including transgenic animals genetically engineered to have tissues that will not be rejected by humans.
For example, a distended artery from a transgenic pig might be used to provide a xenogeneic arterial graft in a human.
The devices and methods can be sized to stretch blood vessels (e.g., veins, arteries) of essentially any size and located in or excised from a variety of sites in the body of the patient or donor or animal. Preferred blood vessels include, but are not limited to, the internal mammary axteries, the gastroepipolic artery, the gastric artery, the radial artery, the femoral artery, and the splenic artery. Other arteries and veins may also be suitable blood vessels for use with the methods and devices.
In a preferred embodiment of the ira vivo distension method, the stretching mechanism is inserted into a donor blood vessel, for example using a catheter, and vessel distension effected over a period of time. Then the stretching mechanism is withdrawn, and a portion of the donor blood vessel section is surgically removed. The ends of the donor vessel can then be sutured end to end to repair the donor vessel, as is commonly done in vascular repair without complication. Some blood vessels used for coronary bypass surgery, such as the gastroepipolic and radial arteries, can be removed with minimal morbidity such that repair is unnecessary. The removed blood vessel section is then ready for use as a graft in a patient in need thereof, who preferably is the same patient supplying the donor vessel.
Grafts for coronary by-pass surgery are typically between about 10 cm and 15 cm in length, whereas grafts for by-pass in the peripheral circulation are typically about 25 cm or more in length. Those of skill in the art can readily optimize the rate of vessel distension.
Distension rates can be linear or nonlinear, and may average, for example, between about 5 and 10 mm/day.
The device can also be used for ifa vitro distension. Currently, a short segment of blood vessel can be salvaged during conventional bypass surgery and an ih vitro organ culture or bioreactor system can be used to grow sufficient graft tissue for a second surgery. Such surgeries represent about 30% of all bypass operations. The methods and devices described herein can be adapted to work with such surgeries, to increase the length of graft material and/or to reduce the required length of the salvaged segment. Stretched blood vessels can be effectively preserved for bypass surgery, for example, using known cryogenic or freeze-drying techniques.
In this method, a portion of a donor blood vessel (e.g., shorter than that needed for a graft) is surgically excised from the patient in need of the graft, and then the vessel portion is stretched over a period of time iya vitro in a medium for cell growth, for example, as in a bioreactor. As used herein, the phrase "medium for cell growth" includes any ih vitro system for facilitating cell division, extra-cellular matrix formation, and growth of vessel tissue. See, for example, U.S. Patent No. 5,899,936 to Goldstein; U.S. Patent No. 5,879,875, to Wiggins, et al.; and U.S. Patent No. 5,888,720 to Mitrani, which describe techniques for organ and tissue culture which can be adapted to the methods described herein.
All or a portion of the distended vessel is then ready for use as a graft in the patient. Where the donor is the recipient of the graft, the result using either approach advantageously is a totally.
autologous, living vascular graft.
Modifications and variations of the present invention will be obvious to those skilled in the art from the foregoing description. Such modifications and variations are intended to come within the scope of the following claims.
A rotary motor could also be used to generate the required linear motion, using techniques known in the art. Alternatively, the prime mover can operate hydraulically. An active device generally requires input over time. The prime mover also can be a passive device such as a spring or a combination of a spring and a damper, where stored mechanical energy is used to push and/or pull the anchored portions of the wires away from each other.
Linear or rotary piezo micro-motor devices (actuators) deliver small step sizes, small forces, have relatively simple control electronics and inherent force overload protection.
Suitable devices are available from a number of vendors, including Micro Pulse Systems, Inc.
Parameters of the operating means include the force applied by the stretching mechanism, the rate and direction of movement of the stretching mechanism, the length of time that the stretching mechanism is operated, and the type of stretching applied (e.g., continuous, cyclical, or intermittent).
The controller controls the operating means. The controller can include a microprocessor that can be activated and programmed to control the stretching process. It preferably can be reprogrammed as needed to control the stretching process, based, for example, on x-ray data or other indications of how the process is proceeding.
The mechanical or hydraulic stretching mechanism works to move the wires apart slowly over a period of up to several weeks. In one embodiment, the passive driver element may be used to provide a pre-determined stretch over time. In another embodiment, the driver may be programmed to operate autonomously, for example to provide a stretch of several centimeters over about ane month. Alternatively, cyclic stretching of increasing peak and mean amplitude may be used. Using piezo actuators, activating the driver can produce incremental movements of the mechanical or hydraulic stretching mechanism as small as a few microns. The prime mover is designed to be force limited to preclude overstretching the vessel. Force limitation is inherent if the piezoelectric actuators are used in either embodiment and, in the case of permanent magnetic motors, can be designed into the electronic driver circuit.
Methods o Use The catheter can be inserted using well-established techniques for catheter insertion.
Briefly, a guide wire is inserted using an insertion catheter and is steered to the target blood vessel, usually by using fluoroscopic techniques. The catheter then slides over the guide wire so that its distal end is located in the lumen of the target blood vessel.
Insertion of the catheter is facilitated by its radio-opaque nature.
In the methods employing shape memory materials that can be activated by a temperature change, the anchor wire and stretching wire typically will need to be maintained at a temperature below body temperature until their distal ends are correctly positioned inside the target blood vessel lumen. Techniques for accomplishing this temperature control are well known to those skilled in the art. For example, chilled saline can be flowed through one or more of the catheter lumens to maintain the temperature of the wire that is inside a catheter lumen below the activation temperature.
The device described with reference to Figures 1 and 2 can be installed and operated as illustrated in Figures 3A-E. In these Figures, blood flow should be from left (proximal) to right (distal). Figure 3A shows a catheter 12 in an inserted position within target blood vessel 30, such that distal end 18 of catheter 12 is in the desired position for deployment of the stretching wire. As stretching wire 14a is deployed, its distal end portion 22a warms to body temperature and changes to a spiral, expanded configuration and engages circumferentially the interior surface 31 of blood vessel 30, as shown in Figure 3B. This engagement causes the stretching wire 14a to be secured to the blood vessel 30 and establishes a distal anchoring point therein.
Next, a proximal anchoring point is established. As shown in Figure 3C, the catheter is first moved proximally (to the left) such that distal end 18 of catheter 12 is in the desired position for deployment of the anchor wire. As anchor wire 14b is deployed, its distal end portion 22b warms to body temperature and changes to a spiral, expanded configuration and engages circumferentially the interior surface 32 of blood vessel 30, as shown in Figure 3D.
This engagement causes the anchor wire 14b to be secured to the blood vessel 30 and establishes a proximal anchoring point therein. These distal and proximal anchoring points, at surfaces 31 and 32, respectively, establish the blood vessel segment to be stretched.
Stretching forces axe then applied to one or both of the wires 14a and 14b.
Production and control of these stretching forces can be provided as described above.
Stretching can be continuous, cyclical, or intermittent, or in a combination thereof. Figure 3E
illustrates that the stretching wire 14a has been pushed and caused the blood vessel 30 to be stretched and grown between points 31 and 32. While the stretching shown in Figure 3E is linear (or rectilinear), stretching also can occur in curvilinear manner or in a combination of rectilinear and curvilinear stretching.
The device described with reference to Figures 1 and 3 can be installed and operated as illustrated in Figures SA-E. In these Figures, blood flow should be from left (proximal) to right (distal). Figure SA shows a catheter 12 in an inserted position within target blood vessel 30, such that distal end 18 of catheter 12 is in the desired position for deployment of the stretching wire. As stretching wire 40 is partially deployed, the tip end poxtion of distal end portion 42 warms to body temperature and changes to a spiral, expanded configuration, forming a spiral 46 which engages circumferentially the interior surface 31 of blood vessel 30, as shown in Figure SB. This engagement causes the stretching wire 14a to be secured to the blood vessel 30 and establishes a distal anchoring point therein.
As stretching wire 40 continues to be deployed, an intermediary portion of the distal end portion 42 transforms into a helical configuration operable as a compression spring 44, as shown in Figure SC. This compression spring 44 has an outer diameter that is smaller than that of the spiral 46, so that the compression spring 44 does not fractionally engage and become anchored to the blood vessel wall.
After the compression spring 44 is fully formed, a proximal anchoring point is established. As shown in Figure SD, the catheter is first moved proximally (to the left) such that distal end 18 of catheter 12 is in the desired position for deployment of the anchor wire.
As anchor wire 50 is deployed, its distal end portion 52 warms to body temperature and changes to a spiral, expanded configuration and engages circumferentially the interior surface 32 of blood vessel 30, as shown in Figure 3D. This engagement causes the anchor wire 50 to be secured to the blood vessel 30 and establishes a proximal anchoring point therein.
These distal and proximal anchoring points, at surfaces 31 and 32, respectively, establish the blood vessel segment to be stretched. Stretching forces are then applied by the release of compression in spring 44, which stretches the blood vessel 30 as shown in Figure SE. It may be convenient in this embodiment to simply leave the catheter in place while stretching occurs.
B. Design Utilizing Combination of Stents and Spryn~s In another embodiment, the intravascular stretching means comprises a pair of stems, wherein the stems, rather than the wire spirals described above, function as the anchoring elements. While a variety of stmt designs are commercially available or otherwise known for use in maintaining blood vessel diameter, the stems of the present methods and devices are designed and used to impart axial forces to increase the length of the vessel.
The Device ahd Compohehts Thereof One example of such a design is illustrated in Figures 6A-B. Figures 6A and 6B
show intravascular device 60, which is comprised of a proximal stmt 62, a distal stmt 64, and a compression spring 66 secured between the distal and proximal stems. One end of the proximal stent 62 is comlected to, or integral with, the proximal end 68a of compression spring 66, and one end of the distal stmt 64 is connected to, or integral with, the distal end 68b of compression spring 66. Figure 6A shows device 60 with spring 66 in its compressed configuration, and Figure 6B shows device 60 with spring 66 in its expanded, or stretched, configuration.
Essentially any stmt suitable for vascular implantation can be adapted for use in the present intravascular device. The stmt preferably is self expanding, but also can deployable by other means (e.g., balloon dilation). The stmt can be of various types, including but not limited to coil, mesh, and porous structures. One example of an expandable stmt is described in U.S. Patent No. 6,033,436 to Steinke, et al. Figure 7 shows one embodiment of a proximal or distal stmt 70, which is integral with compression spring 72 (only partially shown). This anchoring stmt 70 is the structural feature that positively engages the vessel wall (not shown).
Numerous other designs are known in the art or can be routinely adapted therefrom. Some configurations are described in U.S. Patent No. 6,193,744 to Ehr et al. These patents are hereby incorporated by reference.
Preferably, each stmt is between about 5 and 20 mm, more preferably about 10 mm, in length. The diameter of the stmt desirably is selected for the particular donor vessel, the size of which can vary.
The compression spring can be integrally formed with the stents, or the compression spring can be welded or otherwise attached to the stems following fabrication of each component. Preferably, the entire device is fabricated in one piece, i.e. as a single, contiguous assembly.
The device should be formed of and/or coated with a biocompatible material, as known in the art. Preferably, the compression spring is made of or includes a shape memory material, as describe herein (e.g., nickel-titanium alloys and shape memory polymers). The compression spring can alternatively be made from non-shape memory materials (e.g., titanium, stainless steel, or a biocompatible polymer). The stems preferably are also fabricated from a shape memory material, but may be made from a non-shape memory material, as describe herein.
Methods of Use The intravascular device is inserted into the target (i.e. donor) blood vessel. Then, the stems are self expanded (e.g., if they comprise a shape memory material) or are expanded with the use of an installation device, such as a balloon, using or adapting techniques known in the art. The expansion process causes each stmt to become frictionally engaged, and thus anchored, to a circmnferential portion of the interior surface of the blood vessel. The stems are anchored in positions such that the spring therebetween is in compression.
The spring thus exerts an axial, expansion force causing the section of blood vessel between the anchor points to be stretched. The expansion of the compression spring thus causes the length of that blood vessel section to lengthen.
Figures 8A-B illustrate one embodiment of a stmt-type stretching device 80 comprising stents 84 and 86 with compression spring 82 in a compressed configuration (Fig.
8A) and with the compression spring 82 in an expanded or stretched configuration (Fig. 8B).
Figure 8B illustrates how a blood vessel could be stretched in a curvilinear mariner to twice the original length, L. A stmt-type device also could expand to stretch in a.linear (or rectilinear) manner or in combination of curvilinear and rectilinear motion.
C. Other Design Features The methods and devices described herein optionally can include growth factors or other growth stimulating agents (e.g., hormones) to further enhance blood vessel growth. For example, such growth stimulating agents can be delivered to the blood vessel by impregnating the materials forming the wires, stems or other device components.
Alternatively or additionally, the device components can be provided with a suitable coating or reservoirs that can contain and controllably release such agents during the extension process.
Examples of growth factors include vascular endothelial growth factor (VEGF), endothelial cell growth factor (ECGF), basic fibroblast growth factor (bFGF), and platelet derived growth factor (PDGF). Biocompatible polymeric materials for controlled release that are lrnown in the art for drug delivery (see e.g., U.S. Patent No. 5,879,713 to Roth et al.) can be adapted for use with the devices described herein. The devices and methods also can be used in combination with external electric, magnetic, or electromagnetic fields applied as a growth stimulus. See e.g., U.S. Patent No. 4,846,181 to Miller.
The devices also can optionally include appropriate drugs (e.g., therapeutic or prophylactic agents) impregnated into or coated to structural components, for example to minimize infections, thrombosis, inflammatory reactions, scar tissue formation, adhesion formation, and/or other adverse tissue reactions. For example, where tissue growth is to be avoided, certain antifibrotic agents may be present, such as 5-fluourouracil or mitomycin. The device may be more generally provided with coatings that are antibiotic or anti-inflammatory.
The intravascular stretching device also can be designed to limit adhesion formation while installed in the blood vessel. For example, the wires, stems, compression springs, or other components can be impregnated or coated with materials selected to reduce adhesion formation as l~nown in the art. Examples of such coating materials include, but are not limited to, parylene, polytetrafluoroethylene (e.g., TEFLONTM) and chromium (e.g., ME-92~, Armoloy Corp.), which can be used to coat a variety of other metal and polymer substrates.
Application of the Distension Devices and Methods The present devices and methods are useful for forming a vascular graft by axially stretching (i.e. distending or extending) a donor blood vessel to stimulate growth. This stretching can performed iya vivo or in vitro.
While an autologous graft is preferred, the devices and methods described herein also can be applied to an artery from another human or other animal, including transgenic animals genetically engineered to have tissues that will not be rejected by humans.
For example, a distended artery from a transgenic pig might be used to provide a xenogeneic arterial graft in a human.
The devices and methods can be sized to stretch blood vessels (e.g., veins, arteries) of essentially any size and located in or excised from a variety of sites in the body of the patient or donor or animal. Preferred blood vessels include, but are not limited to, the internal mammary axteries, the gastroepipolic artery, the gastric artery, the radial artery, the femoral artery, and the splenic artery. Other arteries and veins may also be suitable blood vessels for use with the methods and devices.
In a preferred embodiment of the ira vivo distension method, the stretching mechanism is inserted into a donor blood vessel, for example using a catheter, and vessel distension effected over a period of time. Then the stretching mechanism is withdrawn, and a portion of the donor blood vessel section is surgically removed. The ends of the donor vessel can then be sutured end to end to repair the donor vessel, as is commonly done in vascular repair without complication. Some blood vessels used for coronary bypass surgery, such as the gastroepipolic and radial arteries, can be removed with minimal morbidity such that repair is unnecessary. The removed blood vessel section is then ready for use as a graft in a patient in need thereof, who preferably is the same patient supplying the donor vessel.
Grafts for coronary by-pass surgery are typically between about 10 cm and 15 cm in length, whereas grafts for by-pass in the peripheral circulation are typically about 25 cm or more in length. Those of skill in the art can readily optimize the rate of vessel distension.
Distension rates can be linear or nonlinear, and may average, for example, between about 5 and 10 mm/day.
The device can also be used for ifa vitro distension. Currently, a short segment of blood vessel can be salvaged during conventional bypass surgery and an ih vitro organ culture or bioreactor system can be used to grow sufficient graft tissue for a second surgery. Such surgeries represent about 30% of all bypass operations. The methods and devices described herein can be adapted to work with such surgeries, to increase the length of graft material and/or to reduce the required length of the salvaged segment. Stretched blood vessels can be effectively preserved for bypass surgery, for example, using known cryogenic or freeze-drying techniques.
In this method, a portion of a donor blood vessel (e.g., shorter than that needed for a graft) is surgically excised from the patient in need of the graft, and then the vessel portion is stretched over a period of time iya vitro in a medium for cell growth, for example, as in a bioreactor. As used herein, the phrase "medium for cell growth" includes any ih vitro system for facilitating cell division, extra-cellular matrix formation, and growth of vessel tissue. See, for example, U.S. Patent No. 5,899,936 to Goldstein; U.S. Patent No. 5,879,875, to Wiggins, et al.; and U.S. Patent No. 5,888,720 to Mitrani, which describe techniques for organ and tissue culture which can be adapted to the methods described herein.
All or a portion of the distended vessel is then ready for use as a graft in the patient. Where the donor is the recipient of the graft, the result using either approach advantageously is a totally.
autologous, living vascular graft.
Modifications and variations of the present invention will be obvious to those skilled in the art from the foregoing description. Such modifications and variations are intended to come within the scope of the following claims.
Claims (35)
1. A device for axially distending a blood vessel to induce growth of the vessel comprising:
an intravascular stretching mechanism attachable directly to an interior lumen portion of the blood vessel; and a means for operating the stretching mechanism to cause the vessel to distend axially.
an intravascular stretching mechanism attachable directly to an interior lumen portion of the blood vessel; and a means for operating the stretching mechanism to cause the vessel to distend axially.
2. The device of claim 1, wherein the intravascular stretching mechanism comprises:
an anchoring wire having a distal end portion; and a stretching wire having a distal end portion;
wherein the distal end portions are separately anchorable to the interior lumen portion at positions axially remote from one another.
an anchoring wire having a distal end portion; and a stretching wire having a distal end portion;
wherein the distal end portions are separately anchorable to the interior lumen portion at positions axially remote from one another.
3. The device of claim 2, wherein the distal end portion of the anchoring wire, the distal end portion of the stretching wire, or both, comprise a shape memory material.
4. The device of claim 3, wherein the shape memory material comprises a shape memory alloy or a shape memory polymer.
5. The device of claim 4, wherein the shape memory material comprises a biodegradable shape memory polymer.
6. The device of claim 3, wherein the distal end portion of the stretching wire changes, in response to a change in temperature effective to trigger a change in the shape memory material, from a substantially straight form into a spiral configuration which fractionally engages a first position in the interior lumen portion of the blood vessel when located therein.
7. The device of claim 6, wherein the distal end portion of the anchoring wire changes, in response to a change in temperature effective to trigger a change in the shape memory material, from a substantially straight form into a spiral configuration which engages a second position in the interior lumen portion of the blood vessel when located therein.
17 The device of claim 6, wherein the stretching wire further comprises ail intermediary portion which changes, in response to a change in temperature effective to trigger a change in the shape memory material, from a substantially straight form into a helical configuration, said helical configuration being operable as a compression spring.
9. The device of claim 2, further comprising a catheter having at least two lumens extending between a proximal end and a distal end, one of said at least two lumens being suitable for delivering the stretching wire into the interior lumen portion of the blood vessel, and another of said at least two lumens being suitable for delivering the anchor wire into the interior lumen portion of the blood vessel.
10. The device of claim 1, wherein the means for operating comprises a prime mover that is mechanically, electromechanically, or hydraulically driven.
11. The device of claim 1, wherein the means for operating the stretching mechanism causes an axial stretching force to be applied to the vessel in a continuous manner.
12. The device of claim 1, wherein the means for operating the stretching mechanism causes an axial stretching force to be applied to the vessel in an intermittent manner.
13. The device of claim 1, wherein the means for operating the stretching mechanism causes an axial stretching force to be applied to the vessel in a cyclical manner.
14. The device of claim l, further comprising a controller for controlling the means for operating the stretching mechanism.
15. The device of claim 1, wherein the intravascular stretching mechanism comprises a first stent, a second stent, and a compression spring operably connected to the first stent and the second stent, the first and second stems being separately anchorable to the interior lumen portion at positions axially remote from one another.
16. The device of claim 15, wherein the first stent, the second stent, the compression spring, or a combination thereof, comprises a shape memory material.
17. The device of claim 16, wherein the shape memory material comprises a shape memory alloy or a shape memory polymer.
18. The device of claim 16, wherein the shape memory material comprises a biodegradable shape memory polymer.
19. The device of claim 1, further comprising a therapeutic or prophylactic agent.
20. The device of claim 19, wherein the a therapeutic or prophylactic agent comprises a growth stimulating agent which can be released in an effective amount to enhance growth of the blood vessel.
21. The device of claim 1, wherein all or a portion of the intravascular stretching mechanism is radio-opaque.
22. A method for distending a blood vessel of a human or animal to induce blood vessel growth, comprising the steps:
inserting into an interior lumen portion of a blood vessel the stretching mechanism of the device of claim 1;
anchoring the stretching mechanism to the interior lumen portion at at least two positions axially remote from one another; and operating the stretching mechanism to axially stretch the blood vessel between said at least two positions over a period of time effective to induce axial growth of the blood vessel.
inserting into an interior lumen portion of a blood vessel the stretching mechanism of the device of claim 1;
anchoring the stretching mechanism to the interior lumen portion at at least two positions axially remote from one another; and operating the stretching mechanism to axially stretch the blood vessel between said at least two positions over a period of time effective to induce axial growth of the blood vessel.
23. The method of claim 22, wherein the stretching occurs in vivo.
24. The method of claim 22, wherein the stretching occurs in vitro in a medium for cell growth.
25. The method of claim 22, wherein the stretching mechanism is operated to apply an axial stretching force to the vessel in a continuous manner.
26. The method of claim 22, wherein the stretching mechanism is operated to apply an axial stretching force to the vessel in an intermittent manner.
27. The method of claim 22, wherein the stretching mechanism is operated to apply an axial stretching force to the vessel in a cyclical manner.
28. The method of claim 22, wherein the blood vessel is selected from the group consisting of an internal mammary artery, a femoral artery, a gastroepipolic artery, a gastric artery, a radial artery, and a splenic artery.
29. The method of claim 22, wherein the intravascular stretching mechanism comprises an anchoring wire having a distal end portion, and a stretching wire having a distal end portion, wherein the distal end portions are separately anchorable to the interior lumen portion at positions axially remote from one another.
30. The method of claim 22, wherein the intravascular stretching mechanism comprises a first stent, a second stent, and a compression spring operably connected to the first stent and the second stent, the first and second stems being separately anchorable to the interior lumen portion at positions axially remote from one another.
31. The method of claim 22, wherein the anchoring of the stretching mechanism comprises dilating a balloon to cause at least a portion of the stretching mechanism to expand and engage the interior lumen portion of the blood vessel.
32. A method of forming a vascular graft for a human or animal in need thereof, comprising:
distending a donor blood vessel by use of the method of claim 22; and excising a portion of the distended donor vessel, said portion thereby providing a vascular graft.
distending a donor blood vessel by use of the method of claim 22; and excising a portion of the distended donor vessel, said portion thereby providing a vascular graft.
33. The method of claim 32, wherein the vessel distension is conducted in vivo.
34. The method of claim 32, wherein the vessel distension is conducted in vitro in a medium for cell growth.
35. The method of claim 32, wherein the donor blood vessel is obtained from a human or transgenic aiumal.
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US27470301P | 2001-03-09 | 2001-03-09 | |
| US60/274,703 | 2001-03-09 | ||
| PCT/US2002/006854 WO2002071980A2 (en) | 2001-03-09 | 2002-03-07 | Intravascular device and method for axially stretching blood vessels |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| CA2439216A1 true CA2439216A1 (en) | 2002-09-19 |
Family
ID=23049281
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CA002439216A Abandoned CA2439216A1 (en) | 2001-03-09 | 2002-03-07 | Intravascular device and method for axially stretching blood vessels |
Country Status (5)
| Country | Link |
|---|---|
| US (2) | US7018402B2 (en) |
| EP (1) | EP1365709A2 (en) |
| JP (1) | JP2004524909A (en) |
| CA (1) | CA2439216A1 (en) |
| WO (1) | WO2002071980A2 (en) |
Families Citing this family (68)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US7351421B2 (en) * | 1996-11-05 | 2008-04-01 | Hsing-Wen Sung | Drug-eluting stent having collagen drug carrier chemically treated with genipin |
| US8038708B2 (en) | 2001-02-05 | 2011-10-18 | Cook Medical Technologies Llc | Implantable device with remodelable material and covering material |
| WO2003003948A1 (en) | 2001-07-06 | 2003-01-16 | Tricardia, L.L.C. | Anti-arrhythmia devices and methods of use |
| WO2004078066A2 (en) | 2003-03-03 | 2004-09-16 | Sinus Rhythm Technologies, Inc. | Primary examiner |
| EP1605866B1 (en) | 2003-03-03 | 2016-07-06 | Syntach AG | Electrical conduction block implant device |
| US20050131520A1 (en) | 2003-04-28 | 2005-06-16 | Zilla Peter P. | Compliant blood vessel graft |
| US7998188B2 (en) | 2003-04-28 | 2011-08-16 | Kips Bay Medical, Inc. | Compliant blood vessel graft |
| WO2005018507A2 (en) * | 2003-07-18 | 2005-03-03 | Ev3 Santa Rosa, Inc. | Remotely activated mitral annuloplasty system and methods |
| WO2005039689A2 (en) | 2003-10-24 | 2005-05-06 | Sinus Rhythm Technologies, Inc. | Methods and devices for creating cardiac electrical blocks |
| SE526861C2 (en) | 2003-11-17 | 2005-11-15 | Syntach Ag | Tissue lesion creation device and a set of devices for the treatment of cardiac arrhythmia disorders |
| US8398693B2 (en) * | 2004-01-23 | 2013-03-19 | Boston Scientific Scimed, Inc. | Electrically actuated medical devices |
| US7744619B2 (en) | 2004-02-24 | 2010-06-29 | Boston Scientific Scimed, Inc. | Rotatable catheter assembly |
| US7922740B2 (en) | 2004-02-24 | 2011-04-12 | Boston Scientific Scimed, Inc. | Rotatable catheter assembly |
| US9398967B2 (en) | 2004-03-02 | 2016-07-26 | Syntach Ag | Electrical conduction block implant device |
| US20080183285A1 (en) * | 2004-06-29 | 2008-07-31 | Micardia Corporation | Adjustable cardiac valve implant with selective dimensional adjustment |
| US7713298B2 (en) * | 2004-06-29 | 2010-05-11 | Micardia Corporation | Methods for treating cardiac valves with adjustable implants |
| EP1768611A4 (en) * | 2004-07-15 | 2009-11-18 | Micardia Corp | Implants and methods for reshaping heart valves |
| US20070073380A1 (en) * | 2004-12-20 | 2007-03-29 | Vazquez Frank B | Longitudinally expanding, rotating & contracting shaped memory superelastic stent |
| US20060212113A1 (en) * | 2005-02-24 | 2006-09-21 | Shaolian Samuel M | Externally adjustable endovascular graft implant |
| US20060238019A1 (en) * | 2005-04-21 | 2006-10-26 | Mark Yu | Brakable wheel hub device |
| WO2007016251A2 (en) * | 2005-07-28 | 2007-02-08 | Cook Incorporated | Implantable thromboresistant valve |
| US20070055368A1 (en) * | 2005-09-07 | 2007-03-08 | Richard Rhee | Slotted annuloplasty ring |
| US7536228B2 (en) | 2006-03-24 | 2009-05-19 | Micardia Corporation | Activation device for dynamic ring manipulation |
| US8235048B2 (en) * | 2006-12-01 | 2012-08-07 | Rex Medical, L.P. | Fallopian tube occlusion device |
| US20080228272A1 (en) * | 2006-12-04 | 2008-09-18 | Micardia Corporation | Dynamically adjustable suture and chordae tendinae |
| US7722560B2 (en) * | 2007-02-09 | 2010-05-25 | The Regents Of The University Of Michigan | Mechanical extension implants for short bowel syndrome |
| US7753915B1 (en) | 2007-06-14 | 2010-07-13 | August Eksler | Bi-directional bone length adjustment system |
| US8663321B2 (en) | 2007-12-06 | 2014-03-04 | L. Van Thomas Crisco | Minimally invasive method for coronary bypass and other treatments |
| US10022250B2 (en) | 2007-12-12 | 2018-07-17 | Intact Vascular, Inc. | Deployment device for placement of multiple intraluminal surgical staples |
| US10166127B2 (en) | 2007-12-12 | 2019-01-01 | Intact Vascular, Inc. | Endoluminal device and method |
| US7896911B2 (en) | 2007-12-12 | 2011-03-01 | Innovasc Llc | Device and method for tacking plaque to blood vessel wall |
| US9375327B2 (en) | 2007-12-12 | 2016-06-28 | Intact Vascular, Inc. | Endovascular implant |
| US8128677B2 (en) | 2007-12-12 | 2012-03-06 | Intact Vascular LLC | Device and method for tacking plaque to a blood vessel wall |
| US9603730B2 (en) | 2007-12-12 | 2017-03-28 | Intact Vascular, Inc. | Endoluminal device and method |
| US9155476B2 (en) | 2008-03-18 | 2015-10-13 | Circa Scientific, Llc | Large surface area temperature sensing device |
| US9833149B2 (en) | 2008-03-18 | 2017-12-05 | Circa Scientific, Llc | Methods, apparatus and systems for facilitating introduction of shaped medical instruments into the body of a subject |
| DK2265193T3 (en) | 2008-04-21 | 2012-01-23 | Nfocus Neuromedical Inc | Embolic devices with braided ball and delivery systems |
| WO2009140437A1 (en) | 2008-05-13 | 2009-11-19 | Nfocus Neuromedical, Inc. | Braid implant delivery systems |
| US8133199B2 (en) | 2008-08-27 | 2012-03-13 | Boston Scientific Scimed, Inc. | Electroactive polymer activation system for a medical device |
| EP2421483B1 (en) * | 2009-04-22 | 2018-08-29 | The Regents of The University of California | Expandable distension device for hollow organ growth |
| SE535690C2 (en) * | 2010-03-25 | 2012-11-13 | Jan Otto Solem | An implantable device and cardiac support kit, comprising means for generating longitudinal movement of the mitral valve |
| US9744339B2 (en) * | 2010-05-12 | 2017-08-29 | Circa Scientific, Llc | Apparatus for manually manipulating hollow organs |
| EP3354210B1 (en) | 2010-09-10 | 2022-10-26 | Covidien LP | Devices for the treatment of vascular defects |
| US8998947B2 (en) | 2010-09-10 | 2015-04-07 | Medina Medical, Inc. | Devices and methods for the treatment of vascular defects |
| US10271973B2 (en) | 2011-06-03 | 2019-04-30 | Intact Vascular, Inc. | Endovascular implant |
| EP3733134A1 (en) | 2012-01-25 | 2020-11-04 | Intact Vascular, Inc. | Endoluminal device |
| WO2014062827A1 (en) | 2012-10-16 | 2014-04-24 | Spence Paul A | Devices, systems, and methods for facilitating flow from the heart to a blood pump |
| WO2014078458A2 (en) | 2012-11-13 | 2014-05-22 | Covidien Lp | Occlusive devices |
| CN105007859B (en) * | 2012-12-26 | 2018-07-03 | 柯惠有限合伙公司 | For the device and method of the treatment of vascular defect |
| US10159486B2 (en) | 2014-05-21 | 2018-12-25 | The Regents Of The University Of Michigan | Fenestrated decoupling system for internal selective attachment to soft tissue organs |
| US10640742B2 (en) | 2014-09-25 | 2020-05-05 | Board Of Supervisors Of Louisiana State University And Agricultural And Mechanical College | Hybrid linear actuator controlled hydraulic cell stretching |
| US10117738B2 (en) | 2015-01-23 | 2018-11-06 | The Regents Of The University Of Michigan | Atraumatic tip geometry for indwelling devices |
| US9375336B1 (en) | 2015-01-29 | 2016-06-28 | Intact Vascular, Inc. | Delivery device and method of delivery |
| US9433520B2 (en) | 2015-01-29 | 2016-09-06 | Intact Vascular, Inc. | Delivery device and method of delivery |
| US9375333B1 (en) | 2015-03-06 | 2016-06-28 | Covidien Lp | Implantable device detachment systems and associated devices and methods |
| WO2017083696A1 (en) * | 2015-11-11 | 2017-05-18 | The Regents Of The University Of California | Degradable intestinal anchor |
| US10993824B2 (en) | 2016-01-01 | 2021-05-04 | Intact Vascular, Inc. | Delivery device and method of delivery |
| EP3448492A4 (en) | 2016-04-28 | 2019-11-27 | The Regents of The University of Michigan | Mechanotransductive bowel extender device having local delivery of medically relevant liquids |
| US10478195B2 (en) | 2016-08-04 | 2019-11-19 | Covidien Lp | Devices, systems, and methods for the treatment of vascular defects |
| US11638655B2 (en) | 2016-11-02 | 2023-05-02 | Daniel Ezra Walzman | Orientable intracranial occlusion device and method |
| US11045177B2 (en) | 2016-11-02 | 2021-06-29 | Daniel Ezra Walzman | Orientable intracranial occlusion device and method |
| CN107137168B (en) * | 2017-06-21 | 2019-07-05 | 青岛容商天下网络有限公司 | Degradable recoverable 4D prints the organic human body support of line style and its application method |
| US11660218B2 (en) | 2017-07-26 | 2023-05-30 | Intact Vascular, Inc. | Delivery device and method of delivery |
| US10675036B2 (en) | 2017-08-22 | 2020-06-09 | Covidien Lp | Devices, systems, and methods for the treatment of vascular defects |
| US11678887B2 (en) | 2018-12-17 | 2023-06-20 | Covidien Lp | Devices, systems, and methods for the treatment of vascular defects |
| EP4054438A1 (en) | 2019-11-04 | 2022-09-14 | Covidien LP | Devices, systems, and methods for treatment of intracranial aneurysms |
| US11931041B2 (en) | 2020-05-12 | 2024-03-19 | Covidien Lp | Devices, systems, and methods for the treatment of vascular defects |
| EP4240280A1 (en) * | 2020-11-04 | 2023-09-13 | Daniel Ezra Walzmann | Orientable intravascular devices and methods |
Family Cites Families (22)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| IT8629545V0 (en) * | 1986-06-12 | 1986-06-12 | Fina Ernesto | SET BALLOON URETERAL CATHETER BALLOON FOR EXTRACTION OF URETERAL STONES |
| US4978348A (en) * | 1988-05-26 | 1990-12-18 | Ilizarov Gavriil A | Compression-distraction apparatus for osteosynthesis |
| US5078726A (en) * | 1989-02-01 | 1992-01-07 | Kreamer Jeffry W | Graft stent and method of repairing blood vessels |
| US5549664A (en) * | 1990-07-31 | 1996-08-27 | Ube Industries, Ltd. | Artificial blood vessel |
| US5344425A (en) * | 1990-09-14 | 1994-09-06 | Interface Biomedical Laboratories, Corp. | Intravascular stent and method for conditioning the surfaces thereof |
| DE4030059A1 (en) * | 1990-09-22 | 1992-03-26 | Bayer Ag | METHOD FOR PRODUCING 5-HYDROXY-3,4,5,6-TETRAHYDRO-PYRIMIDINE DERIVATIVES |
| US5888720A (en) * | 1992-10-27 | 1999-03-30 | Yissum Research And Development Company Of The Hebrew University Of Jerusalem | In vitro micro-organs |
| US5769893A (en) * | 1993-09-29 | 1998-06-23 | Shah; Mrugesh K. | Apparatus and method for promoting growth and repair of soft tissue |
| DE69532976T2 (en) * | 1994-03-14 | 2005-05-04 | Cryolife, Inc. | METHOD OF MANUFACTURING TISSUE FOR IMPLANTATION |
| US5702419A (en) * | 1994-09-21 | 1997-12-30 | Wake Forest University | Expandable, intraluminal stents |
| AU700903B2 (en) * | 1994-10-12 | 1999-01-14 | Focal, Inc. | Targeted delivery via biodegradable polymers |
| US5591195A (en) * | 1995-10-30 | 1997-01-07 | Taheri; Syde | Apparatus and method for engrafting a blood vessel |
| US5879875A (en) * | 1996-06-14 | 1999-03-09 | Biostore New Zealand | Compositions and methods for the preservation of living tissues |
| US5902228A (en) * | 1996-10-11 | 1999-05-11 | Cornell Research Foundation, Inc. | Method and apparatus for support and tubularization of surgical grafts |
| US6033436A (en) * | 1998-02-17 | 2000-03-07 | Md3, Inc. | Expandable stent |
| WO1999042558A1 (en) | 1998-02-20 | 1999-08-26 | Nanogen, Inc. | Advanced active devices and methods for molecular biological analysis and diagnostics |
| WO1999042147A1 (en) * | 1998-02-23 | 1999-08-26 | Massachusetts Institute Of Technology | Biodegradable shape memory polymers |
| ES2265186T3 (en) | 1998-02-23 | 2007-02-01 | Mnemoscience Gmbh | POLYMERS WITH FORM MEMORY. |
| US6663617B1 (en) * | 1998-05-28 | 2003-12-16 | Georgia Tech Research Corporation | Devices for creating vascular grafts by vessel distension using fixed post and moveable driver elements |
| US6641576B1 (en) * | 1998-05-28 | 2003-11-04 | Georgia Tech Research Corporation | Devices for creating vascular grafts by vessel distension using rotatable elements |
| AU4409599A (en) * | 1998-05-28 | 1999-12-13 | Georgia Tech Research Corporation | Autologous vascular grafts created by vessel distension |
| US6193744B1 (en) * | 1998-09-10 | 2001-02-27 | Scimed Life Systems, Inc. | Stent configurations |
-
2002
- 2002-03-07 WO PCT/US2002/006854 patent/WO2002071980A2/en not_active Application Discontinuation
- 2002-03-07 US US10/093,715 patent/US7018402B2/en not_active Expired - Fee Related
- 2002-03-07 EP EP02719146A patent/EP1365709A2/en not_active Withdrawn
- 2002-03-07 CA CA002439216A patent/CA2439216A1/en not_active Abandoned
- 2002-03-07 JP JP2002570940A patent/JP2004524909A/en not_active Withdrawn
-
2006
- 2006-03-09 US US11/371,663 patent/US7300455B2/en not_active Expired - Fee Related
Also Published As
| Publication number | Publication date |
|---|---|
| US7300455B2 (en) | 2007-11-27 |
| EP1365709A2 (en) | 2003-12-03 |
| WO2002071980A3 (en) | 2003-05-01 |
| US7018402B2 (en) | 2006-03-28 |
| US20020133223A1 (en) | 2002-09-19 |
| US20060271162A1 (en) | 2006-11-30 |
| WO2002071980A2 (en) | 2002-09-19 |
| JP2004524909A (en) | 2004-08-19 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| US7018402B2 (en) | Intravascular device and method for axially stretching blood vessels | |
| AU2002360066B2 (en) | Delayed memory device | |
| US10314704B2 (en) | Artificial device deployment apparatus | |
| Small IV et al. | Biomedical applications of thermally activated shape memory polymers | |
| CN102245129B (en) | Repositionable endoluminal support structure and its applications | |
| US7628804B2 (en) | Prosthetic valve with vessel engaging member | |
| US6641576B1 (en) | Devices for creating vascular grafts by vessel distension using rotatable elements | |
| US6322553B1 (en) | Autologous vascular grafts created by vessel distension | |
| US6899669B2 (en) | Autologous vascular grafts created by vessel distension | |
| US20090012354A1 (en) | System and method for intraventricular treatment | |
| JP2008512187A (en) | Prosthetic valve with holes | |
| US10779933B2 (en) | Device, system and method for anchoring to muscle tissue | |
| AU2002250245A1 (en) | Intravascular device and method for axially stretching blood vessels | |
| US20070073380A1 (en) | Longitudinally expanding, rotating & contracting shaped memory superelastic stent | |
| Sokolowski et al. | Applications of Shape-Memory Polymers in Biomedicine |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| FZDE | Discontinued |